索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 引用因子
  • 宇宙IF
  • 西马戈
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 期刊摘要索引目录
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 学者指导
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Simvastatin: Its potential new role in periodontal regeneration

Kinra P,*Khan S

Periodontal therapy is aimed at the restoration of tissues destroyed by disease. However, achieving greater predictability with regenerative therapy requires the introduction of an agent which not only hampers tissue destruction but also enhances the regenerative capabilities of the periodontal tissues. Pharmacologic agents offer great promise in this direction. Simvastatin, which is used for the treatment of hypercholesterolaemia, is a universally accepted and relatively inexpensive drug. Its long-term systemic administration in humans has been shown to result in increased bone mineral density. Local application of simvastatin has been shown to stimulate bone formation in rodents both in vitro and in vivo and in human periodontal ligament cells in vitro. These effects seem to be associated with an increased expression of BMP-2 and reduced formation of metabolites of the mevalonate pathway, which it blocks. Many other mechanisms of action have also been proposed and studied. This article reviews the effects of simvastatin and examines its potential role in periodontal regenerative therapy.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证